-
公开(公告)号:US20230203129A1
公开(公告)日:2023-06-29
申请号:US17786669
申请日:2020-12-16
Applicant: BRACCO IMAGING S.P.A.
Inventor: Erika REITANO , Alessandro MAIOCCHI , Luisa POGGI , Federico CRIVELLIN , Simon HUET , Mathieu CINIER , Olivier KITTEN
IPC: C07K14/71 , C07K1/13 , G01N33/533
CPC classification number: C07K14/71 , C07K1/13 , G01N33/533
Abstract: The present invention provides new polypeptide derivatives binding to Human Epidermal Growth Factor Receptor 2 (HER2) and their conjugates thereof, and to their use as a diagnostic agent, particularly for early detection, patient stratification and treatment monitoring of forms of cancer characterized by over-expression of HER2.
-
公开(公告)号:US20230046541A1
公开(公告)日:2023-02-16
申请号:US17786623
申请日:2020-12-17
Applicant: BRACCO IMAGING S.P.A.
Inventor: Andrea BANIN , Laura GALIMBERTI , Roberta NAPOLITANO , Roberta FRETTA
IPC: C07C229/22 , C07C227/18
Abstract: The present invention relates to the calcium complex of (4RS)(4-carboxy-5,8,11-tris(carboxymethyl)-1-phenyl oxa-5,8,11-triazatridecan-13-oato(5-))pentahydrogen (BOPTA) in the form of a salt, to the process for its preparation and to a formulation comprising said salt.
-
公开(公告)号:US10973934B2
公开(公告)日:2021-04-13
申请号:US16766619
申请日:2019-08-06
Applicant: BRACCO IMAGING S.P.A.
Inventor: Roberta Napolitano , Luciano Lattuada , Zsolt Baranyai , Nicole Guidolin , Giuseppe Marazzi
Abstract: The present invention relates to the RRR/SSS pair of enantiomers of the of Gd(PCTA-tris-glutaric acid), the single enantiomers of the pair, the pharmaceutically acceptable salts thereof, their amide derivatives, and compositions comprising at least 50% of these compounds.
-
公开(公告)号:US20200379070A1
公开(公告)日:2020-12-03
申请号:US16065302
申请日:2016-12-22
Applicant: BRACCO IMAGING S.P.A.
Inventor: Silvio AIME , Dario Livio LONGO , Sonia COLOMBO SERRA , Lorena CONSOLINO , Francesca ARENA
IPC: G01R33/56 , A61K49/10 , A61B5/055 , G01R33/465 , G01R33/48
Abstract: The present invention relates to on the use of exogenous agents having a pool of mobile proton(s) in CEST-MR imaging to generate Chemical Exchange Rotation Transfer/based CEST contrast, and to a ratiometric-based CEST-MR procedure that comprises using these exogenous agents to set-up CERT-based concentration-independent CEST MR imaging, and as responsive agents to set-up CERT-based concentration independent responsiveness.
-
公开(公告)号:US10781188B2
公开(公告)日:2020-09-22
申请号:US16060577
申请日:2016-12-12
Applicant: BRACCO IMAGING S.P.A.
Inventor: Luciano Lattuada , Roberta Napolitano , Valeria Boi , Massimo Visigalli , Silvio Aime , Giovanni Battista Giovenzana , Alberto Fringuello Mingo
IPC: C07D257/02 , A61K49/10 , C07D401/06
Abstract: The present invention relates to new class of functionalized macrocycles capable of chelating paramagnetic metal ions, their chelated complexes with metal ions and the use thereof as contrast agents, particularly suitable for Magnetic Resonance Imaging (MRI) analysis.
-
公开(公告)号:US10780184B2
公开(公告)日:2020-09-22
申请号:US16263769
申请日:2019-01-31
Applicant: BRACCO IMAGING S.P.A.
Inventor: Simona Ghiani , Alessandro Maiocchi , Lara Caminiti , Luigi Miragoli
Abstract: The present invention discloses a solid lipid nanoparticle (SLN) comprising: a) a solid lipid core comprising at least a glyceride and/or at least a fatty acid; b) a mixture of amphiphilic components forming a shell around said core a); c) an alkaline-earth complex with a compound of formula I and/or II: d) at least a fluorescent dye selected from: a cyanine fluorescent dye and/or a polyetherocyclic compound selected from: coumarin, pyrano, quinoline, pyranoquinoline, indole and pyranoindole derivates in acid form or a pharmaceutically acceptable salt thereof. These nanoparticles allow a prolonged blood circulation half-life, show enhanced photostability and improved fluorescence signal. The dye is preserved from degradation and improves the fluorescent quantum yield.
-
公开(公告)号:US10682427B2
公开(公告)日:2020-06-16
申请号:US15535937
申请日:2015-12-18
Applicant: BRACCO IMAGING S.P.A.
Inventor: Alessandro Maiocchi , Chiara Brioschi , Fulvio Uggeri , Giovanni Valbusa
Abstract: The present invention relates to the use of a NIR fluorescent probe comprising an aza-bicycloalkane based cyclic peptide labelled with a Cy5.5 dye moiety in the fluorescence-guided surgery of pathologic regions and to an optical imaging method that comprises using this fluorescent probe for the identification and demarcation of tumor margins during the surgical resection.
-
公开(公告)号:US10407412B2
公开(公告)日:2019-09-10
申请号:US16060754
申请日:2016-12-12
Applicant: BRACCO IMAGING S.P.A.
Inventor: Valeria Boi , Roberta Napolitano , Luciano Lattuada
IPC: A61B5/055 , C07D403/12 , C07D257/02 , A61K49/12 , A61K49/10
Abstract: The present invention relates to new class of dimeric macrocycles capable of chelating paramagnetic metal ions, their chelated complexes with metal ions and the use thereof as contrast agents, particularly suitable for Magnetic Resonance Imaging (MRI) analysis.
-
公开(公告)号:US20190209713A1
公开(公告)日:2019-07-11
申请号:US16256749
申请日:2019-01-24
Applicant: BRACCO IMAGING S.P.A.
Inventor: Silvio AIME , Daniela DELLI CASTELLI , Franco FEDELI , Dario Livio LONGO , Enzo TERRENO , Fulvio UGGERI
IPC: A61K49/10
Abstract: The present invention relates to the use of non-equivalent mobile protons belonging to NMR distinguishable steroisomers of a CEST agent in a ratiometric based CEST imaging procedure and to Lanthanide (III) complex compounds displaying at least two NMR-distinguishable steroisomers in solution useful as concentration independent CEST responsive agents.
-
公开(公告)号:US20180362476A1
公开(公告)日:2018-12-20
申请号:US16060577
申请日:2016-12-12
Applicant: BRACCO IMAGING S.P.A.
Inventor: Luciano LATTUADA , Roberta NAPOLITANO , Valeria BOI , Massimo VISIGALLI , Silvio AIME , Giovanni Battista GIOVENZANA , Alberto FRINGUELLO MINGO
IPC: C07D257/02 , C07D401/06 , A61K49/10
Abstract: The present invention relates to new class of functionalized macrocycles capable of chelating paramagnetic metal ions, their chelated complexes with metal ions and the use thereof as contrast agents, particularly suitable for Magnetic Resonance Imaging (MRI) analysis.5
-
-
-
-
-
-
-
-
-